Hepatitis E Diagnostic Tests Market Size

Hepatitis E Diagnostic Tests Market Size

Hepatitis E Diagnostic Tests Market size was valued at around USD 60 million in 2023 and is estimated to grow at 4.3% CAGR from 2024 to 2032. Hepatitis E diagnostic tests are used to detect the presence of the hepatitis E virus (HEV) in the body and to determine whether an individual has been infected. These tests are crucial for diagnosing hepatitis E, an infection that primarily affects the liver and is often transmitted through contaminated water.

To get key market trends

  Download Free Sample

The rising incidence of hepatitis E worldwide has heightened the demand for effective diagnostic solutions. Hepatitis E, caused by the hepatitis E virus (HEV), has become more prevalent due to factors such as inadequate sanitation and contaminated water sources, especially in developing regions. For instance, according to the World Health Organization (WHO), approximately 20 million hepatitis E virus infections occur globally each year, resulting in an estimated 3.3 million symptomatic cases of hepatitis E. This increase in incidence has underscored the need for reliable diagnostic tests to manage and control the spread of the virus, thereby driving market growth.
 

Furthermore, advancements in diagnostic technologies have significantly propelled market growth. Innovations in molecular diagnostics, such as polymerase chain reaction (PCR) and enzyme immunoassay have enhanced the accuracy, sensitivity, and speed of hepatitis E detection. These technological improvements facilitate early diagnosis, which is crucial for effective disease management and the prevention of outbreaks. Additionally, advancements in point-of-care testing are making diagnostics more accessible, especially in remote and underserved areas.